Cargando…

A role for an HTLV-1 vaccine?

HTLV-1 is a global infection with 5-20 million infected individuals. Although only a minority of infected individuals develop myelopathy, lymphoproliferative malignancy, or inflammatory disorders, infection is associated with immunosuppression and shorter survival. Transmission of HTLV-1 is through...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ratner, Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497876/ https://www.ncbi.nlm.nih.gov/pubmed/36159878 http://dx.doi.org/10.3389/fimmu.2022.953650

Ejemplares similares

Reflections on Some of the Exceptional Features of HTLV-1 and HTLV-1 Research: A Perspective
por: Gallo, Robert C., et al.
Publicado: (2022)

The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein
por: Accolla, Roberto S.
Publicado: (2022)

Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1
por: Tanaka, Yukie, et al.
Publicado: (2022)

Tuning Rex rules HTLV-1 pathogenesis
por: Nakano, Kazumi, et al.
Publicado: (2022)

Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years
por: Santana, Carolina Souza, et al.
Publicado: (2023)

The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study
por: Iwamoto, Naoki, et al.
Publicado: (2022)

HTLV-1 as a Model for Virus and Host Coordinated Immunoediting
por: Mota, Talia M., et al.
Publicado: (2019)

MiR-150 in HTLV-1 infection and T-cell transformation
por: D’Agostino, Donna M., et al.
Publicado: (2022)

T cell receptor repertoire analysis in HTLV-1-associated diseases
por: Clauze, Annaliese, et al.
Publicado: (2022)

HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1
por: Al-Saleem, Jacob, et al.
Publicado: (2019)

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients
por: Rauch, Daniel A., et al.
Publicado: (2011)

HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system
por: Tan, Benjy J. Y., et al.
Publicado: (2022)

Safety of intraocular anti-VEGF antibody treatment under in vitro HTLV-1 infection
por: Zong, Yuan, et al.
Publicado: (2023)

TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals
por: Guerra, Mariele, et al.
Publicado: (2022)

Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection
por: Clements, Danielle M., et al.
Publicado: (2021)

Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression
por: Souza, Flávia dos Santos, et al.
Publicado: (2021)

A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL)
por: Tanaka, Yuetsu, et al.
Publicado: (2022)

A New Flow Cytometry-Based Single Platform for Universal and Differential Serodiagnosis of HTLV-1/2 Infection
por: Pimenta de Paiva, Luciene, et al.
Publicado: (2022)

A Fas(hi) Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation
por: Menezes, Soraya Maria, et al.
Publicado: (2017)

Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression
por: Gomes, Yago Côrtes Pinheiro, et al.
Publicado: (2022)

HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
por: Maksimova, Victoria, et al.
Publicado: (2022)

Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis
por: Zane, Linda, et al.
Publicado: (2012)

The Role of Chemokines in the Pathogenesis of HTLV-1
por: Zargari, Razieh, et al.
Publicado: (2020)

HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients’ T-cells
por: Schnell, Annika P., et al.
Publicado: (2022)

Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world’s largest endemic area
por: Gessain, Antoine, et al.
Publicado: (2023)

The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30-II mRNA
por: Choudhary, Gunjan, et al.
Publicado: (2011)

Comparative virology of HTLV-1 and HTLV-2
por: Martinez, Michael P., et al.
Publicado: (2019)

Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2022)

Subtype Analysis of HTLV‐1 in Patients with HTLV‐1 Uveitis
por: Ono, Ayako, et al.
Publicado: (1994)

Vertical Transmission of HTLV‐1 in HTLV‐1 Carrier Rat
por: Ami, Yoshihiro, et al.
Publicado: (1992)

HTLV-1 infection: role of CTL efficiency
por: Bangham, Charles R. M.
Publicado: (2008)

HBZ and its roles in HTLV-1 oncogenesis
por: Zhao, Tiejun, et al.
Publicado: (2012)

The Role of HBZ in HTLV-1-Induced Oncogenesis
por: Zhao, Tiejun
Publicado: (2016)

Detection of HTLV-1 proviral DNA in cell-free DNA: Potential for non-invasive monitoring of Adult T cell leukaemia/lymphoma using liquid biopsy?
por: Joris, Thomas, et al.
Publicado: (2023)

HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo
por: Martinez, Michael P., et al.
Publicado: (2019)

Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases
por: Kassay, Norbert, et al.
Publicado: (2021)

Predicting and Designing Epitope Ensemble Vaccines against HTLV-1
por: Alam, Saruar, et al.
Publicado: (2020)

The discovery of the first human retrovirus: HTLV-1 and HTLV-2
por: Gallo, Robert C
Publicado: (2005)

Fine tuning of the temporal expression of HTLV-1 and HTLV-2
por: Cavallari, Ilaria, et al.
Publicado: (2013)

Distinct activities of HTLV-1 Tax1 from HTLV-2 Tax2 play key roles in pathogenesis
por: Fujii, Masahiro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_raaul4bi2an0imnvmdat0qjsod